Literature DB >> 19249296

Role of histamine H(4) receptor in allergic conjunctivitis in mice.

Yoshiyuki Nakano1, Yuji Takahashi, Rie Ono, Yasunori Kurata, Yoto Kagawa, Chiaki Kamei.   

Abstract

We investigated the character of histamine H(1) receptor and H(4) receptor in allergic conjunctivitis. Histamine is the most important mediator in allergic conjunctivitis. We measured eye scratching behavior and allergic-like symptoms score, that is, hyperemia and edema in ICR mice, and examined which receptors intimately involved in allergic conjunctivitis. Histamine caused a dose-dependent eye scratching behavior and allergic-like symptoms. Histamine H(1) receptor antagonist (levocabastine) and H(4) receptor antagonist (JNJ7777120) inhibited eye scratching behavior and histamine H(1) receptor antagonist inhibited allergic-like symptoms induced by histamine. Additionally, combination of levocabastine and JNJ7777120 caused more potent inhibition in allergic conjunctivitis. On the other hand, both selective histamine H(1) receptor agonist (HTMT) and selective H(4) receptor agonist (4-methylhistamine) induced a dose-dependent eye scratching behavior and allergic-like symptoms. JNJ7777120 inhibited the effect of HTMT. However, levocabastine caused no inhibition on the response of 4-methylhistamine. H(4) receptor was closely related with allergic conjunctivitis. H(4) receptor antagonists may be effective in allergic conjunctivitis which showed no inhibition by histamine H(1) receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249296     DOI: 10.1016/j.ejphar.2009.02.035

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Histamine induces chemotaxis and phagocytosis in murine bone marrow-derived macrophages and RAW 264.7 macrophage-like cells via histamine H4-receptor.

Authors:  Christoph P Czerner; Andreas Klos; Roland Seifert; Detlef Neumann
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

Review 2.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

3.  Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Authors:  Jack V Greiner; Kimberly Edwards-Swanson; Avner Ingerman
Journal:  Clin Ophthalmol       Date:  2011-01-13

Review 4.  The histamine H4 receptor: from orphan to the clinic.

Authors:  Robin L Thurmond
Journal:  Front Pharmacol       Date:  2015-03-31       Impact factor: 5.810

5.  Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.

Authors:  Eugene B McLaurin; Nicholas P Marsico; Stacey L Ackerman; Joseph B Ciolino; Julia M Williams; Linda Villanueva; David A Hollander
Journal:  Adv Ther       Date:  2014-09-27       Impact factor: 3.845

6.  Model for Studying Anti- Allergic Drugs for Allergic Conjunctivitis in Animals.

Authors:  Yosuke Nakazawa; Mikako Oka; Makoto Takehana
Journal:  Open Med (Wars)       Date:  2017-08-01

Review 7.  The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets.

Authors:  Elden Berla Thangam; Ebenezer Angel Jemima; Himadri Singh; Mirza Saqib Baig; Mahejibin Khan; Clinton B Mathias; Martin K Church; Rohit Saluja
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.